ARS Pharmaceuticals Inc. (SPRY)
12.62
0.13 (1.04%)
At close: Mar 31, 2025, 1:41 PM
ARS Pharmaceuticals Revenue
ARS Pharmaceuticals reported an annual revenue of $89.15M, reflecting a 297063.33% growth. For the quarter ending December 31, 2024, ARS Pharmaceuticals generated $86.58M in revenue.
Revenue (ttm)
$89.15M
Revenue Growth
297063.33%
Price / Sales Ratio
11.47
Revenue / Employee
$575.15K
Employees
155
Market Cap
1.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 89.15M | +297063.33% |
| Dec 31, 2023 | 30K | -97.72% |
| Dec 31, 2022 | 1.32M | -76.10% |
| Dec 31, 2021 | 5.51M | -69.13% |
| Dec 31, 2020 | 17.84M | n/a |